Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey
| dc.contributor.author | Yereli, K | |
| dc.contributor.author | Balcioglu, IC | |
| dc.contributor.author | Ertan, P | |
| dc.contributor.author | Limoncu, E | |
| dc.contributor.author | Onag, A | |
| dc.date.accessioned | 2024-07-18T11:46:39Z | |
| dc.date.available | 2024-07-18T11:46:39Z | |
| dc.description.abstract | The efficacy of albendazole for the treatment of giardiasis has been indicated by previous in-vitro and in-vivo studies. In order to compare the therapeutic efficacy of albendazole and metronidazole, 107 Giardia-positive children (aged 3-15 years), diagnosed by three consecutive positive stool examinations, were enrolled in the study. Of these children, 52 were given a single daily dose of albendazole 10 mg/kg for 5 days, and 55 were given metronidazole 20 mg/kg daily in three doses for 7 days. Parasite eradication was achieved in 47 (90.4%) of 52 children treated with albendazole and 49 (89.1%) of 55 children treated with metronidazole (p > 0.05). These results suggest that albendazole is an effective treatment option for childhood giardiasis. | |
| dc.identifier.issn | 1198-743X | |
| dc.identifier.other | 1469-0691 | |
| dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/2897 | |
| dc.language.iso | English | |
| dc.publisher | ELSEVIER SCI LTD | |
| dc.subject | RESISTANCE | |
| dc.title | Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey | |
| dc.type | Article |